Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antigen-specific Vaccines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00859729
What this trial is testing

Dose Finding Study of a DNA Vaccine Delivered With Intradermal Electroporation in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Uppsala University 15
Testing effectiveness (Phase 2)Study completedNCT01431391
What this trial is testing

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Who this might be right for
Prostatic NeoplasmProstate CancerProstatic Adenocarcinoma
Dendreon 68
Testing effectiveness (Phase 2)Study completedNCT02176746
What this trial is testing

A Phase I/II Study of Active Immunotherapy With Cancer Stem Cells Vaccine for Colorectal Cancer

Who this might be right for
Neoplasms,Colorectal
Fuda Cancer Hospital, Guangzhou 40
Testing effectiveness (Phase 2)Study completedNCT01487863
What this trial is testing

Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticHormone Refractory Prostate CancerCastration-resistant Prostate Cancer
Dendreon 69
Testing effectiveness (Phase 2)WithdrawnNCT02661100
What this trial is testing

A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients

Who this might be right for
Non Small Cell Lung CancerAdvanced Triple Negative Breast CancerSmall Cell Lung Cancer+3 more
Case Comprehensive Cancer Center
Early research (Phase 1)Ended earlyNCT01159964
What this trial is testing

Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 60
Testing effectiveness (Phase 2)Study completedNCT00228189
What this trial is testing

Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients

Who this might be right for
Colorectal CancerLiver Metastases
Radboud University Medical Center 30
Early research (Phase 1)Study completedNCT01339663
What this trial is testing

Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
Fred Hutchinson Cancer Center 12
Early research (Phase 1)Ended earlyNCT00006153
What this trial is testing

Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 45
Not applicableUnknownNCT05557240
What this trial is testing

Neoantigens Phase I Trial in Newly Diagnosed Glioblastoma Patients

Who this might be right for
Glioma, MalignantAntigen-specific VaccinesIndividualized Treatment
Shanghai 10th People's Hospital 10
Very early researchStudy completedNCT03748524
What this trial is testing

Analysis of Antigen Specific B Cell Responses to Immunization With Influenza Virus Vaccine

Who this might be right for
Immunity, Cellular
Washington University School of Medicine 11
Early research (Phase 1)Study completedNCT00874588
What this trial is testing

Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Fukushima Medical University 6
Testing effectiveness (Phase 2)Study completedNCT00529399
What this trial is testing

Effects of Recombinant Human Glutamic Acid Decarboxylase on the Progression of Type 1 Diabetes in New Onset Subjects

Who this might be right for
Type 1 Diabetes Mellitus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 145
Early research (Phase 1)Study completedNCT00003974
What this trial is testing

Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma

Who this might be right for
Lung CancerMalignant Mesothelioma
Roswell Park Cancer Institute 20